Oberst, M. D., Augé, C., Morris, C., Kentner, S., Mulgrew, K., McGlinchey, K., . . . Hammond, S. A. (2018). Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein. Mol Cancer Ther.
Stile di citazione ChicagoOberst, Michael D., et al. "Potent Immune Modulation By MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein." Mol Cancer Ther 2018.
Citazione MLAOberst, Michael D., et al. "Potent Immune Modulation By MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein." Mol Cancer Ther 2018.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.